nach oben

NeuroMolecular Medicine

Erschienen in:

01.09.2009 | Original Paper

MicroRNAs in Mental Health: From Biological Underpinnings to Potential Therapies

verfasst von: Joshua G. Hunsberger, Daniel R. Austin, Guang Chen, Husseini K. Manji

Erschienen in: NeuroMolecular Medicine | Ausgabe 3/2009

Einloggen, um Zugang zu erhalten

Abstract

Psychiatric illnesses are disabling disorders with poorly understood underlying pathophysiologies. However, it is becoming increasingly evident that these illnesses result from disruptions across whole cellular networks rather than any particular monoamine system. Recent evidence continues to support the hypothesis that these illnesses arise from impairments in cellular plasticity cascades, which lead to aberrant information processing in the circuits that regulate mood, cognition, and neurovegetative functions (sleep, appetite, energy, etc.). As a result, many have begun to consider future therapies that would be capable of affecting global changes in cellular plasticity to restore appropriate synaptic function and neuronal connectivity. MicroRNAs (miRNAs) are non-coding RNAs that can repress the gene translation of hundreds of their targets and are therefore well-positioned to target a multitude of cellular mechanisms. Here, we review some properties of miRNAs and show they are altered by stress, glucocorticoids, mood stabilizers, and in a particular psychiatric disorder, schizophrenia. While this field is still in its infancy, we consider their potential for regulating behavioral phenotypes and targeting key predicted signaling cascades that are implicated in psychiatric illness. Clearly, considerable research is required to better determine any therapeutic potential of targeting miRNAs; however, these agents may provide the next generation of effective therapies for psychiatric illnesses.

Belmaker, R. H., & Agam, G. (2008). Major depressive disorder. New England Journal of Medicine, 358(1), 55–68.PubMedCrossRef

Beveridge, N. J., Tooney, P. A., Carroll, A. P., Gardiner, E., Bowden, N., Scott, R. J., et al. (2008). Dysregulation of miRNA 181b in the temporal cortex in schizophrenia. Human Molecular Genetics, 17(8), 1156–1168.PubMedCrossRef

Bhattacharyya, S. N., Habermacher, R., Martine, U., Closs, E. I., & Filipowicz, W. (2006). Relief of microRNA-mediated translational repression in human cells subjected to stress. Cell, 125(6), 1111–1124.PubMedCrossRef

Bremner, J. D., Elzinga, B., Schmahl, C., & Vermetten, E. (2008). Structural and functional plasticity of the human brain in posttraumatic stress disorder. Progress in Brain Research, 167, 171–186.PubMedCrossRef

Cerqueira, J. J., Pego, J. M., Taipa, R., Bessa, J. M., Almeida, O. F., & Sousa, N. (2005). Morphological correlates of corticosteroid-induced changes in prefrontal cortex-dependent behaviors. Journal of Neuroscience, 25(34), 7792–7800.PubMedCrossRef

Chaudhuri, K., & Chatterjee, R. (2007). MicroRNA detection and target prediction: Integration of computational and experimental approaches. DNA and Cell Biology, 26(5), 321–337.PubMedCrossRef

Chen, G., & Manji, H. K. (2006). The extracellular signal-regulated kinase pathway: An emerging promising target for mood stabilizers. Current Opinion in Psychiatry, 19(3), 313–323.PubMedCrossRef

Cheng, H. Y., Papp, J. W., Varlamova, O., Dziema, H., Russell, B., Curfman, J. P., et al. (2007). MicroRNA modulation of circadian-clock period and entrainment. Neuron, 54(5), 813–829.PubMedCrossRef

Coyle, J. T., & Duman, R. S. (2003). Finding the intracellular signaling pathways affected by mood disorder treatments. Neuron, 38(2), 157–160.PubMedCrossRef

Crosby, M. E., Kulshreshtha, R., Ivan, M., & Glazer, P. M. (2009). MicroRNA regulation of DNA repair gene expression in hypoxic stress. Cancer Research, 69(3), 1221–1229.PubMedCrossRef

Cryan, J. F., Kelly, P. H., Neijt, H. C., Sansig, G., Flor, P. J., & van Der Putten, H. (2003). Antidepressant and anxiolytic-like effects in mice lacking the group III metabotropic glutamate receptor mGluR7. European Journal of Neuroscience, 17(11), 2409–2417.PubMedCrossRef

Czeh, B., Perez-Cruz, C., Fuchs, E., & Flugge, G. (2008). Chronic stress-induced cellular changes in the medial prefrontal cortex and their potential clinical implications: Does hemisphere location matter? Behavioural Brain Research, 190(1), 1–13.PubMedCrossRef

Diorio, D., Viau, V., & Meaney, M. J. (1993). The role of the medial prefrontal cortex (cingulate gyrus) in the regulation of hypothalamic-pituitary-adrenal responses to stress. Journal of Neuroscience, 13(9), 3839–3847.PubMed

Drevets, W. C. (2000). Functional anatomical abnormalities in limbic and prefrontal cortical structures in major depression. Progress in Brain Research, 126, 413–431.PubMedCrossRef

Drevets, W. C., Ongur, D., & Price, J. L. (1998). Neuroimaging abnormalities in the subgenual prefrontal cortex: Implications for the pathophysiology of familial mood disorders. Molecular Psychiatry, 3(3), 220–226, 190–221.PubMedCrossRef

Drevets, W. C., Price, J. L., Simpson, J. R., Jr., Todd, R. D., Reich, T., Vannier, M., et al. (1997). Subgenual prefrontal cortex abnormalities in mood disorders. Nature, 386(6627), 824–827.PubMedCrossRef

Drevets, W. C., Savitz, J., & Trimble, M. (2008). The subgenual anterior cingulate cortex in mood disorders. CNS Spectrums, 13(8), 663–681.PubMed

Duman, R. S. (2004). Role of neurotrophic factors in the etiology and treatment of mood disorders. Neuromolecular Medicine, 5(1), 11–25.PubMedCrossRef

Fish, E. W., Shahrokh, D., Bagot, R., Caldji, C., Bredy, T., Szyf, M., et al. (2004). Epigenetic programming of stress responses through variations in maternal care. Annals of the New York Academy of Sciences, 1036, 167–180.PubMedCrossRef

Goodwin, F. K., & Jamison, K. R. (2007). Manic-depressive illness: Bipolar disorders and recurrent depression (2nd ed.). Oxford; New York: Oxford University Press.

Grippo, A. J., & Johnson, A. K. (2009). Stress, depression and cardiovascular dysregulation: A review of neurobiological mechanisms and the integration of research from preclinical disease models. Stress, 12(1), 1–21.PubMedCrossRef

Hansen, T., Olsen, L., Lindow, M., Jakobsen, K. D., Ullum, H., Jonsson, E., et al. (2007). Brain expressed microRNAs implicated in schizophrenia etiology. PLoS ONE, 2(9), e873.PubMedCrossRef

Hasler, G., Drevets, W. C., Gould, T. D., Gottesman, I. I., & Manji, H. K. (2006). Toward constructing an behaviroal phenotype strategy for bipolar disorders. Biological Psychiatry, 60(2), 93–105.PubMedCrossRef

Kato, T. (2008). Molecular neurobiology of bipolar disorder: A disease of ‘mood-stabilizing neurons’? Trends in Neurosciences, 31(10), 495–503.PubMedCrossRef

Keck, P. E., Jr., McElroy, S. L., Strakowski, S. M., Stanton, S. P., Kizer, D. L., Balistreri, T. M., et al. (1996). Factors associated with pharmacologic noncompliance in patients with mania. Journal of Clinical Psychiatry, 57(7), 292–297.PubMed

Kocerha, J., Faghihi, M. A., Lopez-Toledano, M. A., Huang, J., Ramsey, A. J., Caron, M. G., et al. (2009). MicroRNA-219 modulates NMDA receptor-mediated neurobehavioral dysfunction. Proceedings of the National Academy of Science USA, 106, 3507–3512.CrossRef

Kupfer, D. J. (2005). The increasing medical burden in bipolar disorder. JAMA, 293(20), 2528–2530.PubMedCrossRef

Lang, U. E., Puls, I., Muller, D. J., Strutz-Seebohm, N., & Gallinat, J. (2007). Molecular mechanisms of schizophrenia. Cellular Physiology and Biochemistry, 20(6), 687–702.PubMedCrossRef

Leung, A. K., Calabrese, J. M., & Sharp, P. A. (2006). Quantitative analysis of Argonaute protein reveals microRNA-dependent localization to stress granules. Proceedings of the National Academy of Science USA, 103(48), 18125–18130.CrossRef

Leung, A. K., & Sharp, P. A. (2007). microRNAs: A safeguard against turmoil? Cell, 130(4), 581–585.PubMedCrossRef

Malleret, G., Haditsch, U., Genoux, D., Jones, M. W., Bliss, T. V., Vanhoose, A. M., et al. (2001). Inducible and reversible enhancement of learning, memory, and long-term potentiation by genetic inhibition of calcineurin. Cell, 104(5), 675–686.PubMed

Manji, H. K., Gottesman, I. I., & Gould, T. D. (2003). Signal transduction and genes-to-behaviors pathways in psychiatric diseases. Science STKE, 2003(207), pe49.CrossRef

Marsit, C. J., Eddy, K., & Kelsey, K. T. (2006). MicroRNA responses to cellular stress. Cancer Research, 66(22), 10843–10848.PubMedCrossRef

McGowan, P. O., Sasaki, A., D’Alessio, A. C., Dymov, S., Labonte, B., Szyf, M., et al. (2009). Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse. Nature Neuroscience, 12(3), 342–348.PubMedCrossRef

Miller, M. M., & McEwen, B. S. (2006). Establishing an agenda for translational research on PTSD. Annals of the New York Academy of Sciences, 1071, 294–312.PubMedCrossRef

Mitsukawa, K., Mombereau, C., Lotscher, E., Uzunov, D. P., van der Putten, H., Flor, P. J., et al. (2006). Metabotropic glutamate receptor subtype 7 ablation causes dysregulation of the HPA axis and increases hippocampal BDNF protein levels: Implications for stress-related psychiatric disorders. Neuropsychopharmacology, 31(6), 1112–1122.PubMed

Mulkey, R. M., Endo, S., Shenolikar, S., & Malenka, R. C. (1994). Involvement of a calcineurin/inhibitor-1 phosphatase cascade in hippocampal long-term depression. Nature, 369(6480), 486–488.PubMedCrossRef

Neumeister, A., Wood, S., Bonne, O., Nugent, A. C., Luckenbaugh, D. A., Young, T., et al. (2005). Reduced hippocampal volume in unmedicated, remitted patients with major depression versus control subjects. Biological Psychiatry, 57(8), 935–937.PubMedCrossRef

Perkins, D. O., Jeffries, C. D., Jarskog, L. F., Thomson, J. M., Woods, K., Newman, M. A., et al. (2007). microRNA expression in the prefrontal cortex of individuals with schizophrenia and schizoaffective disorder. Genome Biology, 8(2), R27.PubMedCrossRef

Pittenger, C., & Duman, R. S. (2008). Stress, depression, and neuroplasticity: A convergence of mechanisms. Neuropsychopharmacology, 33(1), 88–109.PubMedCrossRef

Pulkkinen, K., Malm, T., Turunen, M., Koistinaho, J., & Yla-Herttuala, S. (2008). Hypoxia induces microRNA miR-210 in vitro and in vivo ephrin-A3 and neuronal pentraxin 1 are potentially regulated by miR-210. FEBS Letters, 582(16), 2397–2401.PubMedCrossRef

Rainer, J., Ploner, C., Jesacher, S., Ploner, A., Eduardoff, M., Mansha, M., et al. (2009). Glucocorticoid-regulated microRNAs and mirtrons in acute lymphoblastic leukemia. Leukemia, 23, 746–752.PubMedCrossRef

Rajewsky, N. (2006). microRNA target predictions in animals. Nature Genetics, 38(Suppl), S8–S13.PubMedCrossRef

Sapolsky, R. M., Romero, L. M., & Munck, A. U. (2000). How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions. Endocrine Reviews, 21(1), 55–89.PubMedCrossRef

Sethupathy, P., Megraw, M., & Hatzigeorgiou, A. G. (2006). A guide through present computational approaches for the identification of mammalian microRNA targets. Nature Methods, 3(11), 881–886.PubMedCrossRef

Shaltiel, G., Chen, G., & Manji, H. K. (2007). Neurotrophic signaling cascades in the pathophysiology and treatment of bipolar disorder. Current Opinion in Pharmacology, 7(1), 22–26.PubMedCrossRef

Sklar, P., Smoller, J. W., Fan, J., Ferreira, M. A., Perlis, R. H., Chambert, K., et al. (2008). Whole-genome association study of bipolar disorder. Molecular Psychiatry, 13(6), 558–569.PubMedCrossRef

Stark, K. L., Xu, B., Bagchi, A., Lai, W. S., Liu, H., Hsu, R., et al. (2008). Altered brain microRNA biogenesis contributes to phenotypic deficits in a 22q11-deletion mouse model. Nature Genetics, 40(6), 751–760.PubMedCrossRef

Tabares-Seisdedos, R., & Rubenstein, J. L. (2009). Chromosome 8p as a potential hub for developmental neuropsychiatric disorders: Implications for schizophrenia, autism and cancer. Molecular Psychiatry, 14, 563–589.PubMedCrossRef

Uchida, S., Nishida, A., Hara, K., Kamemoto, T., Suetsugi, M., Fujimoto, M., et al. (2008). Characterization of the vulnerability to repeated stress in Fischer 344 rats: Possible involvement of microRNA-mediated down-regulation of the glucocorticoid receptor. European Journal of Neuroscience, 27(9), 2250–2261.PubMedCrossRef

Vreugdenhil, E., Verissimo, C. S., Mariman, R., Kamphorst, J. T., Barbosa, J. S., Zweers, T., et al. (2009). MicroRNAs miR-18 and miR-124a downregulate the glucocorticoid receptor: Implications for glucocorticoid responsiveness in the brain. Endocrinology, 150, 2220–2228.PubMedCrossRef

Wang, J. H., & Kelly, P. T. (1997). Postsynaptic calcineurin activity downregulates synaptic transmission by weakening intracellular Ca²⁺ signaling mechanisms in hippocampal CA1 neurons. Journal of Neuroscience, 17(12), 4600–4611.PubMed

Weaver, I. C., Cervoni, N., Champagne, F. A., D’Alessio, A. C., Sharma, S., Seckl, J. R., et al. (2004). Epigenetic programming by maternal behavior. Nature Neuroscience, 7(8), 847–854.PubMedCrossRef

Wellman, C. L. (2001). Dendritic reorganization in pyramidal neurons in medial prefrontal cortex after chronic corticosterone administration. Journal of Neurobiology, 49(3), 245–253.PubMedCrossRef

Winder, D. G., Mansuy, I. M., Osman, M., Moallem, T. M., & Kandel, E. R. (1998). Genetic and pharmacological evidence for a novel, intermediate phase of long-term potentiation suppressed by calcineurin. Cell, 92(1), 25–37.PubMedCrossRef

Yang, M., Lee, J. E., Padgett, R. W., & Edery, I. (2008). Circadian regulation of a limited set of conserved microRNAs in Drosophila. BMC Genomics, 9, 83.PubMedCrossRef

Zhou, R., Yuan, P., Wang, Y., Hunsberger, J. G., Elkahloun, A., Wei, Y., et al. (2008). Evidence for selective microRNAs and their effectors as common long-term targets for the actions of mood stabilizers. Neuropsychopharmacology, 34, 1395–1405.PubMedCrossRef

Zhu, Y., Kalbfleisch, T., Brennan, M. D., & Li, Y. (2009). A microRNA gene is hosted in an intron of a schizophrenia-susceptibility gene. Schizophrenia Research, 109, 86–89.PubMedCrossRef

Titel: MicroRNAs in Mental Health: From Biological Underpinnings to Potential Therapies
verfasst von: Joshua G. Hunsberger
Daniel R. Austin
Guang Chen
Husseini K. Manji
Publikationsdatum: 01.09.2009
Verlag: Humana Press Inc
Erschienen in: NeuroMolecular Medicine / Ausgabe 3/2009
Print ISSN: 1535-1084
Elektronische ISSN: 1559-1174
DOI: https://doi.org/10.1007/s12017-009-8070-5

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Thrombektomie auch bei großen Infarkten von Vorteil

16.05.2024 Ischämischer Schlaganfall Nachrichten

Auch ein sehr ausgedehnter ischämischer Schlaganfall scheint an sich kein Grund zu sein, von einer mechanischen Thrombektomie abzusehen. Dafür spricht die LASTE-Studie, an der Patienten und Patientinnen mit einem ASPECTS von maximal 5 beteiligt waren.

Schwindelursache: Massagepistole lässt Otholiten tanzen

14.05.2024 Benigner Lagerungsschwindel Nachrichten

Wenn jüngere Menschen über ständig rezidivierenden Lagerungsschwindel klagen, könnte eine Massagepistole der Auslöser sein. In JAMA Otolaryngology warnt ein Team vor der Anwendung hochpotenter Geräte im Bereich des Nackens.

Schützt Olivenöl vor dem Tod durch Demenz?

10.05.2024 Morbus Alzheimer Nachrichten

Konsumieren Menschen täglich 7 Gramm Olivenöl, ist ihr Risiko, an einer Demenz zu sterben, um mehr als ein Viertel reduziert – und dies weitgehend unabhängig von ihrer sonstigen Ernährung. Dafür sprechen Auswertungen zweier großer US-Studien.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2009

microRNAs in Gliomas: Small Regulators of a Big Problem

microRNA Regulation of Synaptic Plasticity

Gene Dysregulation in Huntington’s Disease: REST, MicroRNAs and Beyond

The Therapeutic Potential of microRNAs in Nervous System Damage, Degeneration, and Repair

Macro Role(s) of MicroRNAs in Fragile X Syndrome?